| Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain T Shichita, E Hasegawa, A Kimura, R Morita, R Sakaguchi, I Takada, ... Nature medicine 18 (6), 911-917, 2012 | 468 | 2012 |
| Anti‐high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats K Liu, S Mori, HK Takahashi, Y Tomono, H Wake, T Kanke, Y Sato, ... The FASEB Journal 21 (14), 3904-3916, 2007 | 450 | 2007 |
| Anti-high mobility group box-1 monoclonal antibody protects the blood–brain barrier from ischemia-induced disruption in rats J Zhang, HK Takahashi, K Liu, H Wake, R Liu, T Maruo, I Date, T Yoshino, ... Stroke 42 (5), 1420-1428, 2011 | 335 | 2011 |
| Anti–high mobility group box‐1 antibody therapy for traumatic brain injury Y Okuma, K Liu, H Wake, J Zhang, T Maruo, I Date, T Yoshino, A Ohtsuka, ... Annals of neurology 72 (3), 373-384, 2012 | 265 | 2012 |
| The protein CD63 is in platelet dense granules, is deficient in a patient with Hermansky-Pudlak syndrome, and appears identical to granulophysin. M Nishibori, B Cham, A McNicol, A Shalev, N Jain, JM Gerrard The Journal of clinical investigation 91 (4), 1775-1782, 1993 | 183 | 1993 |
| Tumour lineage-homing cell-penetrating peptides as anticancer molecular delivery systems E Kondo, K Saito, Y Tashiro, K Kamide, S Uno, T Furuya, M Mashita, ... Nature communications 3 (1), 951, 2012 | 182 | 2012 |
| High-mobility group box protein 1 neutralization reduces development of diet-induced atherosclerosis in apolipoprotein E–deficient mice P Kanellakis, A Agrotis, TS Kyaw, C Koulis, I Ahrens, S Mori, ... Arteriosclerosis, thrombosis, and vascular biology 31 (2), 313-319, 2011 | 175 | 2011 |
| Platelet dense granule membranes contain both granulophysin and P-selectin (GMP-140) SJ Israels, JM Gerrard, YV Jacques, A McNicol, B Cham, M Nishibori, ... | 172 | 1992 |
| Stimulation of α7 nicotinic acetylcholine receptor inhibits CD14 and the toll-like receptor 4 expression in human monocytes R Hamano, HK Takahashi, H Iwagaki, T Yoshino, M Nishibori, N Tanaka Shock 26 (4), 358-364, 2006 | 136 | 2006 |
| Role of recA/RAD51 family proteins in mammals. M Kawabata, T Kawabata, M Nishibori Acta Medica Okayama 59 (1), 1-9, 2005 | 131 | 2005 |
| Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson's disease T Sasaki, K Liu, T Agari, T Yasuhara, J Morimoto, M Okazaki, H Takeuchi, ... Experimental neurology 275, 220-231, 2016 | 130 | 2016 |
| Characterization of histamine release from the rat hypothalamus as measured by in vivo microdialysis Y Itoh, R Oishi, M Nishibori, K Saeki Journal of neurochemistry 56 (3), 769-774, 1991 | 124 | 1991 |
| Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1–RAGE interaction YU Okuma, K Liu, H Wake, R Liu, Y Nishimura, Z Hui, K Teshigawara, ... Neuropharmacology 85, 18-26, 2014 | 120 | 2014 |
| Two polymorphic forms of human histamine methyltransferase: structural, thermal, and kinetic comparisons JR Horton, K Sawada, M Nishibori, X Zhang, X Cheng Structure 9 (9), 837-849, 2001 | 119 | 2001 |
| Therapeutic effects of anti-HMGB1 monoclonal antibody on pilocarpine-induced status epilepticus in mice L Fu, K Liu, H Wake, K Teshigawara, T Yoshino, H Takahashi, S Mori, ... Scientific reports 7 (1), 1179, 2017 | 115 | 2017 |
| Effects of HMGB1 on ischemia-reperfusion injury in the rat heart S Oozawa, S Mori, T Kanke, H Takahashi, K Liu, Y Tomono, M Asanuma, ... Circulation Journal 72 (7), 1178-1184, 2008 | 112 | 2008 |
| E prostanoid 2 (EP2)/EP4‐mediated suppression of antigen‐specific human T‐cell responses by prostaglandin E2 M Okano, Y Sugata, T Fujiwara, R Matsumoto, M Nishibori, K Shimizu, ... Immunology 118 (3), 343-352, 2006 | 112 | 2006 |
| Therapeutic potential of an anti-high mobility group box-1 monoclonal antibody in epilepsy J Zhao, Y Wang, C Xu, K Liu, Y Wang, L Chen, X Wu, F Gao, Y Guo, J Zhu, ... Brain, behavior, and immunity 64, 308-319, 2017 | 110 | 2017 |
| Metformin directly binds the alarmin HMGB1 and inhibits its proinflammatory activity T Horiuchi, N Sakata, Y Narumi, T Kimura, T Hayashi, K Nagano, K Liu, ... Journal of Biological Chemistry 292 (20), 8436-8446, 2017 | 110 | 2017 |
| Nafamostat mesilate is an extremely potent inhibitor of human tryptase S Mori, Y Itoh, R Shinohata, T Sendo, R Oishi, M Nishibori Journal of pharmacological sciences 92 (4), 420-423, 2003 | 108 | 2003 |
